Published September 2021
| Version v1
Journal article
Stereotactic Body Radiation Therapy With a High Maximum Dose Improves Local Control, Cancer-Specific Death, and Overall Survival in Peripheral Early-Stage Non-Small Cell Lung Cancer
Creators
- 1. Radiation Oncology Center, Ofuna Chuo Hospital, Kamakura, Kanagawa (Japan)
- 2. Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama (Japan)
Description
We investigated whether delivery of a high biologically effective dose (BED) to primary tumors affects systemic outcomes of cancer-specific death (CSD) and overall survival (OS) rates after stereotactic body radiation therapy (SBRT) in patients with early-stage non-small cell lung cancer (ES-NSCLC).
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2021.04.014Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2021.04.014;
- PII
- S0360301621003758;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 111
- Journal Issue
- 1
- Journal Page Range
- p. 143-151
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 53124707
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- DEATH; EFFECTIVE RADIATION DOSES; LUNGS; NEOPLASMS; PATIENTS; RADIOTHERAPY
- Descriptors DEC
- BODY; DISEASES; DOSES; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIATION DOSES; RADIOLOGY; RESPIRATORY SYSTEM; THERAPY
Optional Information
- Copyright
- Copyright (c) 2021 Elsevier Inc. All rights reserved.